This company listing is no longer active
La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Kazia Therapeutics Gestion
Gestion contrôle des critères 0/4
We currently do not have sufficient information about the CEO.
Informations clés
John Friend
Directeur général
AU$1.6m
Rémunération totale
| Pourcentage du salaire du PDG | 47.1% |
| Durée du mandat du directeur général | less than a year |
| Propriété du PDG | n/a |
| Durée moyenne d'occupation des postes de direction | less than a year |
| Durée moyenne du mandat des membres du conseil d'administration | 1.3yrs |
Mises à jour récentes de la gestion
Recent updates
We're Not Worried About Kazia Therapeutics' (ASX:KZA) Cash Burn
Jun 24
We're Not Worried About Kazia Therapeutics' (ASX:KZA) Cash Burn
Feb 24We Take A Look At Why Kazia Therapeutics Limited's (ASX:KZA) CEO Compensation Is Well Earned
Nov 03We Think Kazia Therapeutics (ASX:KZA) Can Easily Afford To Drive Business Growth
Sep 23We Think Kazia Therapeutics (ASX:KZA) Can Afford To Drive Business Growth
May 04When Will Kazia Therapeutics Limited (ASX:KZA) Turn A Profit?
Mar 27Could The Kazia Therapeutics Limited (ASX:KZA) Ownership Structure Tell Us Something Useful?
Feb 28What Can We Learn About Kazia Therapeutics' (ASX:KZA) CEO Compensation?
Feb 01
We Think Kazia Therapeutics (ASX:KZA) Can Afford To Drive Business Growth
Jan 06Bullish: Analysts Just Made An Incredible Upgrade To Their Kazia Therapeutics Limited (ASX:KZA) Forecasts
Dec 11Kazia Therapeutics Limited (ASX:KZA): When Will It Breakeven?
Nov 26Analyse de la rémunération des PDG
| Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
|---|---|---|---|
| Jun 30 2023 | AU$2m | AU$743k | -AU$20m |
| Mar 31 2023 | n/a | n/a | -AU$23m |
| Dec 31 2022 | n/a | n/a | -AU$25m |
| Sep 30 2022 | n/a | n/a | -AU$25m |
| Jun 30 2022 | AU$1m | AU$430k | -AU$25m |
Rémunération vs marché: John's total compensation ($USD1.03M) is above average for companies of similar size in the Australian market ($USD295.83K).
Rémunération et revenus: John's compensation has increased whilst the company is unprofitable.
PDG
John Friend (53 yo)
less than a year
Titularisation
AU$1,576,913
Compensation
Dr. John E. Friend, II, M. D., serves as Chief Executive Officer at Kazia Therapeutics Limited since May 01, 2023 and since August 1, 2023 serves as Managing Director and Director and served as Chief Medic...
Équipe de direction
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| CEO, MD & Interim Chairman | less than a year | AU$1.58m | pas de données | |
| Chief Financial Officer | 1.8yrs | AU$1.05m | pas de données | |
| Company Secretary | less than a year | pas de données | pas de données |
0.8yrs
Durée moyenne de l'emploi
Gestion expérimentée: KZA's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.
Membres du conseil d'administration
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| CEO, MD & Interim Chairman | less than a year | AU$1.58m | pas de données | |
| Independent Non-Executive Director | 8.4yrs | AU$94.00k | 0.36% A$ 68.5k | |
| Member of Scientific Advisory Board | 1.3yrs | pas de données | pas de données | |
| Independent Non-Executive Director | 11yrs | AU$94.00k | 0.42% A$ 79.4k | |
| Director | less than a year | AU$7.12k | pas de données | |
| Member of Scientific Advisory Board | 1.3yrs | pas de données | pas de données | |
| Member of Scientific Advisory Board | 1.3yrs | pas de données | pas de données | |
| Member of Scientific Advisory Board | 1.3yrs | pas de données | pas de données |
1.3yrs
Durée moyenne de l'emploi
61yo
Âge moyen
Conseil d'administration expérimenté: KZA's board of directors are not considered experienced ( 1.3 years average tenure), which suggests a new board.